ストックスクリーナーアプリを入手
2.55
2.00%
0.05
アフターアワーズ：
2.55
前日終値:
$2.50
開ける：
$2.51
24時間の取引高:
51,680
Relative Volume:
0.41
時価総額：
$107.42M
収益：
$52.84M
当期純損益:
$-11.11M
株価収益率:
-9.2998
EPS:
-0.2742
ネットキャッシュフロー:
$-9.12M
1週間 パフォーマンス:
-13.85%
1か月 パフォーマンス:
-17.21%
6か月 パフォーマンス:
-30.71%
1年 パフォーマンス:
+22.01%
1日の値動き範囲:
$2.50
$2.60
1週間の範囲:
$2.32
$2.95
52週間の値動き範囲:
$2.0705
$5.08
Apyx Medical Corp Stock (APYX) Company Profile
Compare APYX vs ABT, MDT, SYK, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
APYX
Apyx Medical Corp
|
2.55 | 124.69M | 52.84M | -11.11M | -9.12M | -0.2742 |
ABT
Abbott Laboratories
|
97.50 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
86.38 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
275.43 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
42.60 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.15 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Apyx Medical Corp Stock (APYX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-11 | アップグレード | BTIG Research | Neutral → Buy |
| 2025-12-16 | 開始されました | Roth Capital | Buy |
| 2025-11-14 | アップグレード | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-11-12 | アップグレード | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2024-10-17 | 開始されました | BTIG Research | Neutral |
| 2023-07-14 | 開始されました | Stephens | Overweight |
| 2022-05-20 | 開始されました | Lake Street | Buy |
| 2019-04-02 | 繰り返されました | Dougherty & Company | Buy |
すべてを表示
Apyx Medical Corp (APYX) 最新ニュース
Apyx Medical Corp (APYX-Q) Stock Price and News - The Globe and Mail
Apyx Medical’s Renuvion Shows 30% Elastin Density Increase in Published Study - Minichart
APYX Initiates Coverage On by Maxim Group -- Price Target Announ - GuruFocus
Apyx Medical reports study results on Renuvion skin treatment - Investing.com
Apyx Medical Corporation (APYX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Maxim Initiates Apyx Medical at Buy With $6 Price Target - marketscreener.com
Every participant in Apyx Medical's study reported improved skin elasticity, radiance and youthfulness - Stock Titan
Apyx Medical: Negative Cash Flow And High Valuation (NASDAQ:APYX) - Seeking Alpha
Apyx Medical Corporation(NasdaqGS: APYX) added to S&P Global BMI Index - marketscreener.com
Apyx Medical Stock Price Forecast. Should You Buy APYX? - StockInvest.us
APYX INVESTOR NOTICE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Apyx Medical Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class ActionAPYX - TMX Newsfile
Apyx Medical Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Apyx Medical (APYX) Q2 2026 Earnings Call Transcript - The Globe and Mail
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Apyx Medical Sees GLP-1 Boom Fueling Demand for Renuvion, AYON Body Contouring - MarketBeat
Apyx Medical at Canaccord Genuity: bets on surgical aesthetics By Investing.com - Investing.com India
Apyx Medical at Canaccord Genuity: bets on surgical aesthetics - Investing.com
HC Wainwright Predicts Weaker Earnings for Apyx Medical - MarketBeat
Apyx Medical Corp (BOV.MU) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Sei Investments Co. Buys 448,174 Shares of Apyx Medical Corporation $APYX - MarketBeat
Apyx Medical Corporation (NASDAQ:APYX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Apyx Medical (NASDAQ:APYX) Issues Quarterly Earnings Results, Beats Expectations By $0.01 EPS - marketbeat.com
Apyx Medical Corp (APYX) Stock News Today - TradingKey
Apyx Medical Corp (APYX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Earnings call transcript: Apyx Medical tops Q2 2026 estimates, shares slip after hours - Investing.com South Africa
APYX Q2 2026 Earnings: Narrower Loss Beats Estimates; Shares SlipRevenue Breakdown Analysis - dars.gov.et
Apyx Medical Corp (APYX) (Q2 2026) Earnings Call Highlights: Revenue Surges 22% on Power Lipo ... - Yahoo Finance UK
Apyx Medical Q2 Earnings Call Highlights - MarketBeat
Apyx Medical (APYX) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Apyx Medical Corp 2026: Revenue $13.88M, EPS ($0.07) — 10-Q Summary - TradingView
Apyx Medical Corp. R (BOV.MU) Q2 FY2026 earnings call transcript - Yahoo Finance
Apyx Medical Reports Q2 2026 Revenue of $13.9M, Surgical Aesthetics Up 28% - TradingView
Apyx Medical Corporation Reports Second Quarter 2026 Financial Results - Yahoo Finance
APYX|Apyx Medical Corp|Price:4.179|Chg%:+0.079 - tradingkey.com
Apyx Medical CEO and CFO to Hold Aug. 11 Investor Fireside Chat - Stock Titan
Apyx Medical Corporation to Participate in the Canaccord Genuity 46th Annual Growth Conference - The Manila Times
Apyx Medical Corp (APYX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Apyx Medical Corp (APYX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Apyx Medical Corp (APYX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
APYX|Apyx Medical Corp|Price:3.850|Chg%:-0.070 - TradingKey
Apyx Medical Corp (APYX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Apyx Medical Corp (APYX) Balance Sheet - TradingKey
APYX|Apyx Medical Corp|Price:4.290|Chg%:+0.110 - TradingKey
Apyx Medical Corp (APYX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TradingKey - TradingKey
APYX|Apyx Medical Corp|Price:4.140| - TradingKey
Why is DeFi Development Corp. (DFDV) Betting on Apyx - Kavout | AI
Apyx Medical Corporation Reconstitutes Board Committees – SEC 8-K Filing Details, July 24, 2026 - Minichart
Apyx Medical Corp (APYX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Apyx Medical Schedules Live Q&A on Second-Quarter Results Aug. 6 - Stock Titan
Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026 - Yahoo Finance
Apyx Medical Corp (APYX) 財務データ
収益
当期純利益
現金流量
EPS
Apyx Medical Corp (APYX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Roman Shawn David | Chief Operating Officer |
Jun 15 '26 |
Option Exercise |
3.23 |
15,000 |
48,450 |
15,000 |
| CITRONOWICZ MOSHE | Senior Vice President |
Mar 15 '26 |
Option Exercise |
1.80 |
37,000 |
66,600 |
493,504 |
| Roman Shawn David | Chief Operating Officer |
Jan 27 '26 |
Option Exercise |
1.80 |
12,000 |
21,600 |
12,000 |
0.26%
0.38%
大文字化:
|
ボリューム (24 時間):